Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells

Xiaoyun Lu, Zhi Chun Ding, Yang Cao, Chufeng Liu, Tsadik Habtetsion, Miao Yu, Henrique Lemos, Huda Salman, Hongyan Xu, Andrew L. Mellor, Gang Zhou

Research output: Contribution to journalArticlepeer-review

44 Scopus citations

Fingerprint

Dive into the research topics of 'Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells'. Together they form a unique fingerprint.

Medicine & Life Sciences